I-Mab Announces Executive Appointments
Mr. Yeh will be based in Shanghai, China and report directly to Dr. Jingwu Zang. He will join I-Mab's Board after the necessary process is completed. As the Company upgrades its worldwide operations and strengthens network with international investors, Mr. Yeh will be leading key aspects of I-Mab's strategic investor interactions, global alliance management and major facilities across the world. Before joining I-Mab, Mr. Yeh was Chief Financial Officer and Head of Strategic Operations at Abbisko Therapeutics. Before joining I-Mab, Dr. Hayslip was Vice President of Clinical Development at Nektar Therapeutics.